Rapid access to rare natural pyranosides using 1,2-diacetal protected
intermediates
Steven V. Ley,* Dafydd R. Owen and Kieron E. Wesson
Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge,
UK CB2 1EW
The synthesis of six rare methylpyranosides from common
manno- and galacto-pyranoside starting materials has been
achieved by the expedient use of 1,2-diacetal protecting
group methodology highlighting its compatibility with a
number of other common synthetic procedures.
responding butane-2,3-diacetal (BDA) intermediates which
may be further manipulated in the expedient synthesis of some
rare monosaccharides using a range of standard synthetic pro-
cedures. These reactions take place with no degradation or loss
of the 1,2-diacetal protecting group.
Typically the BDA intermediates such as 3 and 5 may be
prepared by the direct reaction of butane-2,3-dione 1, which is
both cheap and commercially available, with the parent mono-
saccharide in the presence of catalytic camphorsulfonic acid
(CSA) and trimethyl orthoformate in boiling methanol
(Scheme 1).2 The protection reaction may also be carried out at
room temperature in high yield using boron trifluoride–diethyl
ether as a Lewis acid (Scheme 1). The highly crystalline BDA
products need little further purification. The protection of the
trans-1,2-diol in monosaccharide 2 in the presence of a cis-1,2-
diol pair and 1,3-related pair makes this high yielding, selective
process highly attractive. The single step BDA procedure also
eliminates several steps from conventional approaches to this
level of protecting group selectivity.4
These BDA protected intermediates were subjected to several
standard synthetic manipulations in the synthesis of some
monosaccharide targets. The protected monosaccharide 3 was
readily permethylated using sodium hydride and methyl iodide
(Scheme 2). Deprotection of the diacetal 6 in quantitative yield,
using trifluroacetic acid and water (9:1) at room temperature
yielded methyl curamicoside 7, a component of everinomycin C
8 (Fig. 1) which is a member of the orthosomycin family of
antibiotics.5 These antibiotics feature several unusual mono-
saccharide components (Fig. 1) which were readily synthesised
using this diacetal methodology. An added attractive aspect to
the deprotection process was the volatility of the reaction by-
products, leaving evaporation as the only purification process
necessary.
The use of 1,2-diacetals as protecting groups for trans-1,2-diols
has been shown to be a particularly useful method for the effi-
cient construction of complex, biologically significant oligo-
saccharides.1 Recently, several parameters for the design and
exploitation of these 1,2-dione reagents for the direct protection
of trans-1,2-diols have been established.2 Although relatively
few 1,2-diones are effective in these reactions, they have proved
to bea versatileand powerfulnewprotectinggroup protocol. The
high selectivity for trans-1,2-diols, in the presence of other
polyols, rapidly leads to protected monosaccharides amenable
for further synthetic manipulation. The additional tuning effect
on the latent glycosidation reactivity of these 1,2-diacetal pro-
tected building blocks in oligosaccharide assembly further
enhances their synthetic utility.3
In this work we describe the high yielding, selective protec-
tion reaction of methyl-α--mannopyranoside and methyl-α-
-galactopyranoside with butane-2,3-dione, affording the cor-
OH
OH
OH
OMe
O
OH
O
i. or ii.
O
O
HO
HO
+
O
O
OMe
OMe
OMe
i. 95%
ii. 99%
3
1
2
OH
OMe
OH
HO
O
HO
HO
O
O
Returning to the synthetic manipulations, selective iodin-
ation of the 6-hydroxy of 3 was possible by the procedure of
Garegg and Samuelsson 6
O
i.
+
O
HO
OMe
allowing catalytic hydrogenation to
O
OMe
OMe
convert the manno-configuration of 9 to a BDA protected
rhamnopyranoside intermediate 10 (Scheme 2). Deprotection
yielded methyl-α--rhamnopyranoside 11, the unnatural
rhamnose configuration, which is the main constituent of the
80%
1
4
5
Scheme 1 i, cat. CSA, CH(OME)3, MeOH, heat; ii, cat. BF3ؒOEt2,
CH(OMe)3, MeOH, room temp.
OH
OH
OMe
OMe
OMe
OMe
OMe
OH
O
OMe
O
O
O
HO
HO
i. NaH, ii. MeI
TFA:H2O (9:1)
94%
HO
HO
O
O
O
O
DMF
86%
OMe
3
6
7
11
OMe
OMe
OMe
OMe
OMe
OMe
OH
TFA:H2O (9:1)
I
OMe
99%
OH
O
I2, PPh3, Imidazole
O
H2, Pd/C
O
O
O
O
Et2NH, MeOH
86%
Toluene, heat
85%
OMe
OMe
OMe
OMe
9
10
i. BuLi, ii. CS2
iii. MeI, THF
S
OMe
75%
OMe
O
SMe
TFA:H2O (9:1)
85%
Bu3SnH, AIBN
O
O
O
HO
HO
O
O
O
O
Toluene, heat
73%
OMe
OMe
OMe
OMe
OMe
14
13
12
Scheme 2
J. Chem. Soc., Perkin Trans. 1, 1997
2805